Search research articles
Contact Us
Filters
Showing results (91-100 of 100) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 100 results.
Nature
|
October 6, 1998
Abiotic nitrogen reduction on the early Earth
J A Brandes, N Z Boctor, G D Cody, et al.
The Journal of Clinical Investigation
|
May 1, 1979
Folate distribution in cultured human cells. Studies on 5,10-CH2-H4PteGlu reductase deficiency
D S Rosenblatt, B A Cooper, S Lue-Shing, et al.
Kidney International
|
July 8, 2000
Comparing different methods of assessing body composition in end-stage renal failure
B A Cooper, A Aslani, M Ryan, et al.
The New England Journal of Medicine
|
March 15, 1984
Homocystinuria and megaloblastic anemia responsive to vitamin B12 therapy. An inborn error of metabolism due to a defect in cobalamin metabolism
S Schuh, D S Rosenblatt, B A Cooper, et al.
American Journal of Medical Genetics
|
March 1, 1993
Symptomatic and asymptomatic methylenetetrahydrofolate reductase deficiency in two adult brothers
J C Haworth, L A Dilling, R A Surtees, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
February 1, 1988
T-cell depletion with ricin A-chain T101 in allogeneic bone marrow transplantation to prevent severe graft-versus-host disease
A A Fauser, C Shustik, A Langleben, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie
|
February 1, 1990
Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial
G S Hedderich, D J Petsikas, B A Cooper, et al.
Journal of Medicinal Chemistry
|
September 15, 1995
erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships
R C Schnur, M L Corman, R J Gallaschun, et al.
Journal of Medicinal Chemistry
|
September 15, 1995
Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives
R C Schnur, M L Corman, R J Gallaschun, et al.
European Journal of Cancer Care
|
January 19, 2016
The symptom phenotype of oncology outpatients remains relatively stable from prior to through 1 week following chemotherapy
C Miaskowski, B A Cooper, B Aouizerat, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 100) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 100 results.
Nature
|
October 6, 1998
Abiotic nitrogen reduction on the early Earth
J A Brandes, N Z Boctor, G D Cody, et al.
The Journal of Clinical Investigation
|
May 1, 1979
Folate distribution in cultured human cells. Studies on 5,10-CH2-H4PteGlu reductase deficiency
D S Rosenblatt, B A Cooper, S Lue-Shing, et al.
Kidney International
|
July 8, 2000
Comparing different methods of assessing body composition in end-stage renal failure
B A Cooper, A Aslani, M Ryan, et al.
The New England Journal of Medicine
|
March 15, 1984
Homocystinuria and megaloblastic anemia responsive to vitamin B12 therapy. An inborn error of metabolism due to a defect in cobalamin metabolism
S Schuh, D S Rosenblatt, B A Cooper, et al.
American Journal of Medical Genetics
|
March 1, 1993
Symptomatic and asymptomatic methylenetetrahydrofolate reductase deficiency in two adult brothers
J C Haworth, L A Dilling, R A Surtees, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
February 1, 1988
T-cell depletion with ricin A-chain T101 in allogeneic bone marrow transplantation to prevent severe graft-versus-host disease
A A Fauser, C Shustik, A Langleben, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie
|
February 1, 1990
Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial
G S Hedderich, D J Petsikas, B A Cooper, et al.
Journal of Medicinal Chemistry
|
September 15, 1995
erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships
R C Schnur, M L Corman, R J Gallaschun, et al.
Journal of Medicinal Chemistry
|
September 15, 1995
Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives
R C Schnur, M L Corman, R J Gallaschun, et al.
European Journal of Cancer Care
|
January 19, 2016
The symptom phenotype of oncology outpatients remains relatively stable from prior to through 1 week following chemotherapy
C Miaskowski, B A Cooper, B Aouizerat, et al.
Page
of 10